181
Views
2
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients

, , , , , , ORCID Icon & show all
Pages 338-341 | Received 02 Jul 2018, Accepted 05 Sep 2018, Published online: 30 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wan-Hsuan Hsu, Chi-Kuei Hsu & Chih-Cheng Lai. (2023) Ceftobiprole medocaril for the treatment of pneumonia. Expert Review of Anti-infective Therapy 21:6, pages 551-563.
Read now

Articles from other publishers (1)

Alberto Antonelli, Tommaso Giani, Marco Coppi, Vincenzo Di Pilato, Fabio Arena, Olga Lorenza Colavecchio, Viola Conte, Anne Santerre Henriksen, Gian Maria Rossolini, Luigi Principe, Elisabetta Pagani, Irene Galanti, Claudio Scarparo, Guendalina Vaggelli, Antonella Mencacci, Francesca Orecchioni, Carla Fontana, Maria Labonia, Gabriele Bianco, Vittorio Sambri, Floriana Campanile & Alessandra Bielli. (2019) Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates. Journal of Antimicrobial Chemotherapy 74:12, pages 3453-3461.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.